Get early access! Join the Twelve Data AI Assistant waitlist now.
6.5 EUR
0
0%
Last update Sep 4, 7:31 PM CEST
Market closed
Day range
6.5
6.5
Previous close
6.5
Open
6.5
Access this stock data via API
Subscribe
Innocan Pharma Corporation
6.50
0
0%

Statistics

Valuation metrics
Market cap
0
Enterprise value
-4.26M
Trailing P/E (ttm)
-650
Forward P/E
PEG ratio
2.17
Price/Sales (ttm)
0
Price/Book (mrq)
283.98
Enterprise Value/Revenue
-0.17
Enterprise Value/EBITDA
4.12
Overview
Shares outstanding
247.41M
Float
Shares short
% Held by insiders
% Held by institutions
Average volume (10 days)
3.23K
Average volume (90 days)
1.47K
Price summary
52-Week low
0.10
52-Week high
9.00
52-Week change
97.59 101,658.3%
Beta
50-Day moving average
0.86
200-Day moving average
0.30
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Jun 30, 2025
Profitability
Profit margin
88.96%
Operating margin
3.15%
Operational effectiveness
Return on assets
-19.81%
Return on equity
-26.12%
Income statement
Revenue (ttm)
25.10M
Revenue per share (ttm)
0.11
Quarterly revenue growth (yoy)
-10.13%
Gross profit (ttm)
22.33M
EBITDA
0
Net income to common (ttm)
-1.56M
Diluted EPS (ttm)
-0.01
Quarterly earnings growth (yoy)
-19.39%
Balance sheet
Total cash (mrq)
0
Total cash per share (mrq)
Total debt (mrq)
1.19M
Total Debt/Equity (mrq)
0.21
Current ratio (mrq)
370.24%
Book value per share (mrq)
0.02
Cash flow
Cash flow statement
480.13K
Levered free cash flow (LFCF)
-1.56M
Market closed

Exchange is currently closed
Main market opens in 16 minutes

07:43
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CEST, UTC+02:00).